Trials / Completed
CompletedNCT02459795
To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 469 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ingenol Mebutate (Perrigo) | |
| DRUG | Ingenol Mebutate (Reference) | |
| DRUG | Placebo gel |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-06-02
- Last updated
- 2021-11-02
- Results posted
- 2021-01-22
Source: ClinicalTrials.gov record NCT02459795. Inclusion in this directory is not an endorsement.